YONGAN PHARMACEUTICAL
00236512.470.16% ( +0.02 )
YONGAN PHARMACEUTICAL (002365)
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces nutrition and health foods, water reducers and other r...
- Open
- 12.18
- High
- 12.59
- Low
- 12.11
- Prev. Close
- 12.45
- Volume
- 181.82K
- Turnover
- 226.56M
- Avg Price
- 12.46
- Bid/Ask Ratio
- --
- Amplitude
- 3.86%
- 52wk High
- 22.62
- Volume Ratio
- 0.41
- Turnover Ratio
- 6.17%
YONGAN PHARMACEUTICAL Analyst Rating
View MoreForecast & Rating
May 14, 2018Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 29, 2025 at 05:37 AM
YONGAN PHARMACEUTICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 25.4963 million yuan, a year-on-year decrease of 58.78%
- Zhitong · Oct 29, 2025 at 02:54 AM
YONGAN PHARMACEUTICAL: Net profit for the third quarter was 13.0005 million yuan, a year-on-year increase of 38.75%
- Zhitong · Sep 24, 2025 at 04:12 AM
YONGAN PHARMACEUTICAL: Plans to acquire minority shareholder equity in its controlling subsidiary for 27 million yuan
- Zhitong · Sep 8, 2025 at 06:47 AM
YONGAN PHARMACEUTICAL: Controlling shareholder reduces holdings by 410,000 shares
- Zhitong · Sep 3, 2025 at 02:57 AM
YONGAN PHARMACEUTICAL's actual controller Chen Yong lifts the lien
- Zhitong · Aug 27, 2025 at 03:59 AM
YONGAN PHARMACEUTICAL released its performance for the first half of the year, with a net profit attributable to the parent company of 12.4957 million yuan, a year-on-year decrease of 76.19%
